膳食营养补充产品制造商技源集团今日申购

Group 1 - The core viewpoint of the news is that Jiyuan Group is launching an IPO to raise funds for expanding its production capacity and enhancing its R&D capabilities in the dietary supplement industry [1][2]. - Jiyuan Group plans to issue 50.01 million shares at a price of 10.88 yuan per share, with a total post-issue share capital of approximately 400 million shares [1]. - The company has established itself as a leading supplier in the global HMB market, holding over 50% market share and possessing multiple core patents and clinical data [2]. Group 2 - The company has shown steady growth in revenue and profit, with projected revenues of 9.47 billion yuan, 8.92 billion yuan, and 10.02 billion yuan from 2022 to 2024, and net profits of 1.42 billion yuan, 1.6 billion yuan, and 1.74 billion yuan respectively [2]. - The funds raised from the IPO, totaling 603 million yuan, will be allocated to the construction of a nutritional health raw material production base, expansion of production lines, and a technology innovation center [2]. - Jiyuan Group aims to continue its focus on technological innovation, increasing R&D investment, and optimizing production processes to enhance product quality and brand value [3].